110 related articles for article (PubMed ID: 23440769)
1. Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus.
Kurosaki Y; Tsukushi T; Munekata S; Akahoshi T; Moriya T; Ogawa Z
J Clin Lab Anal; 2013 May; 27(3):231-6. PubMed ID: 23440769
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
3. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
4. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
[TBL] [Abstract][Full Text] [Related]
5. Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait.
Akanji AO; Mojiminiyi OA; Abdella N
Eur J Clin Nutr; 2000 Jun; 54(6):508-13. PubMed ID: 10878654
[TBL] [Abstract][Full Text] [Related]
6. Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease.
Hirano T; Hayashi T; Adachi M; Taira T; Hattori H
Metabolism; 2007 Apr; 56(4):462-3. PubMed ID: 17379001
[TBL] [Abstract][Full Text] [Related]
7. Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes.
Saito M; Eto M; Kaku K
Metabolism; 2002 Aug; 51(8):964-9. PubMed ID: 12145767
[TBL] [Abstract][Full Text] [Related]
8. Apolipoproteins a-I and B as components of metabolic syndrome with respect to diabetes status: a factor analysis.
Esteghamati A; Zandieh A; Esteghamati A; Sadaghiani MS; Zandieh B; Rezaeitabar E; Nakhjavani M
Metab Syndr Relat Disord; 2012 Aug; 10(4):280-5. PubMed ID: 22471842
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
[TBL] [Abstract][Full Text] [Related]
10. Glycated apolipoprotein B-A surrogate marker of subclinical atherosclerosis.
Dev K; Sharma SB; Garg S; Aggarwal A; Madhu SV
Diabetes Metab Syndr; 2016; 10(2):78-81. PubMed ID: 26614298
[TBL] [Abstract][Full Text] [Related]
11. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.
Barkas F; Elisaf M; Liberopoulos E; Liontos A; Rizos EC
Atherosclerosis; 2016 Apr; 247():58-63. PubMed ID: 26868509
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells.
Passarelli M; Tang C; McDonald TO; O'Brien KD; Gerrity RG; Heinecke JW; Oram JF
Diabetes; 2005 Jul; 54(7):2198-205. PubMed ID: 15983222
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans.
Park JS; Cho MH; Nam JS; Yoo JS; Lee YB; Roh JM; Ahn CW; Jee SH; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC
Metabolism; 2010 May; 59(5):677-82. PubMed ID: 19914667
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-II levels and coronary artery disease in subjects with and without diabetes: a study with use of a specific radioimmunoassay for apolipoprotein A-II.
Wentworth MA; O'Brien T; Rastogi A; Kottke BA
Mayo Clin Proc; 1993 Jun; 68(6):556-60. PubMed ID: 8098786
[TBL] [Abstract][Full Text] [Related]
15. Association between insulin resistance and apolipoprotein B in normoglycemic Koreans.
Sung KC; Hwang ST
Atherosclerosis; 2005 May; 180(1):161-9. PubMed ID: 15823289
[TBL] [Abstract][Full Text] [Related]
16. HDL subparticles and coronary artery disease in NIDDM.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
[TBL] [Abstract][Full Text] [Related]
19. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo.
Doucet C; Huby T; Ruiz J; Chapman MJ; Thillet J
Atherosclerosis; 1995 Nov; 118(1):135-43. PubMed ID: 8579623
[TBL] [Abstract][Full Text] [Related]
20. High density lipoprotein and diabetes mellitus.
Tanaka A; Uchimura I; Maezawa H
Bull Tokyo Med Dent Univ; 1984 Jun; 31(2):85-91. PubMed ID: 6430582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
